Rezension:

Gloomy tales pogenericcialis "If there's a weakness in the Abbott story, it's establishedpharmaceuticals," said Joanne Wuensch, an analyst with BMOCapital Markets. She noted the company is making managementchanges in hopes of revitalizing the business segment.

Bewertung: